
Syntekabio to Unveil AI Drug Discovery Platforms at UKC 2022
Syntekabio will present its AI-based drug discovery platforms DeepMatcher® and NEO-ARS™ at the UKC 2022 on August 19, aimed at fostering collaboration between U.S. and Korean professionals. The firm strives …
Syntekabio to Unveil AI Drug Discovery Platforms at UKC 2022 Read More